SEQMATIC, LLC - WHOLE EXOME SEQUENCING (WES) OF 95 GENOMIC DEOXYRIBONUCLEIC ACID (DNA) SAMPLES DERIVED FROM ACUTE LIVER FAILURE PATIENTS
Key Details
Description
WHOLE EXOME SEQUENCING (WES) OF 95 GENOMIC DEOXYRIBONUCLEIC ACID (DNA) SAMPLES DERIVED FROM ACUTE LIVER FAILURE PATIENTS
Context & Analysis
On Jan 8, 2026, Department of Health and Human Services obligated $44,340.06 to SEQMATIC, LLC for whole exome sequencing (wes) of 95 genomic deoxyribonucleic acid (dna) samples derived from acute liver failure patients. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: competed under sap with 9 offers received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in FREMONT, CA. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.